MFAP2 Promotes Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Activating TGF-β/SMAD2/3 Signaling Pathway [Retraction]
OncoTargets and Therapy · 2026-06 · Volume 19 · 1-2
DOI: 10.2147/ott.s633631 ↗Kurz gefasst
Fachartikel in der Zeitschrift OncoTargets and Therapy, 2026-06. Verfasst von Jian-Kai Wang und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wang, J., Wang, W., Cai, H., Du, B., Mai, P., Zhang, L., Ma, W., Hu, Y., Feng, S., & Miao, G. (2026). MFAP2 Promotes Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Activating TGF-β/SMAD2/3 Signaling Pathway [Retraction]. OncoTargets and Therapy, Volume 19, 1-2. https://doi.org/10.2147/ott.s633631
Vancouver
Wang J, Wang W, Cai H, Du B, Mai P, Zhang L, et al. MFAP2 Promotes Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Activating TGF-β/SMAD2/3 Signaling Pathway [Retraction]. OncoTargets and Therapy. 2026;Volume 19:1-2. doi:10.2147/ott.s633631
BibTeX
@article{Wang2026,
author = {Wang, Jian-Kai and Wang, Wen-Juan and Cai, Hong-Yi and Du, Bin-Bin and Mai, Ping and Zhang, Li-Juan and Ma, Wen and Hu, Yong-Guo and Feng, Shi-Fang and Miao, Guo-Ying},
title = {MFAP2 Promotes Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Activating TGF-β/SMAD2/3 Signaling Pathway [Retraction]},
journal = {OncoTargets and Therapy},
year = {2026},
volume = {Volume 19},
pages = {1--2},
doi = {10.2147/ott.s633631}
}
EUVIMED